Skip to main content

is infliximab (remicade) safe during pregnancy? expert-backed

is infliximab (remicade) safe during pregnancy? expert-backed
On this page

Infliximab (Remicade) during pregnancy: **Safe with caution** in 2nd/3rd trimesters; avoid 1st trimester. Learn dosage limits, alternatives, and expert-backed

Shubhra Mishra

By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛

Are you a qualified maternal-health or nutrition expert? Join our reviewer circle.

Wondering about another food?

Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.

Quick verdict: ⚠️ Infliximab (Remicade) is generally avoided during pregnancy unless absolutely necessary because it’s a tumor necrosis factor (TNF) inhibitor linked to potential risks like preterm birth, low birth weight, and possible immune system effects on the baby. If you’re already taking it, your provider will carefully weigh the benefits against risks and may adjust your dose or timing. Safer alternatives exist for most conditions.

It’s 2:17 a.m., and you’re scrolling through your phone, heart pounding, when you see the words that stop you cold: “Is infliximab Remicade safe during pregnancy?” Maybe you just found out you’re pregnant after months of trying, or perhaps you’ve been managing a chronic condition like Crohn’s or rheumatoid arthritis with Remicade and now you’re panicking about whether to keep taking it. Or maybe you’ve already taken it before realizing you were pregnant—and now you’re Googling until your eyes hurt.

You’re not alone. Many women with autoimmune diseases face this same heart-stopping question, and the answer isn’t always straightforward. Remicade (infliximab) is a powerful biologic medication used to treat severe inflammatory conditions like Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. But because it works by suppressing the immune system—something critical for a growing baby—its safety during pregnancy is a hotly debated topic among doctors. The good news? Current guidelines from the American College of Obstetricians and Gynecologists (ACOG) and the FDA suggest avoiding Remicade unless the benefits clearly outweigh the risks. The bad news? The decision isn’t black and white, and it depends on your specific condition, trimester, and whether you’ve already taken the medication.

In this article, we’ll break down everything you need to know about Remicade and pregnancy: whether it’s safe in each trimester, what the research actually says, how it might affect your baby, and what safer alternatives exist. We’ll also address the most common worries—like whether it’s okay to take it in the first trimester or if generic versions are any safer. By the end, you’ll have a clear plan for what to do next, whether you’re deciding whether to start Remicade, already taking it, or just found out you’re pregnant.

Let’s start with the most important question: Is infliximab Remicade safe during pregnancy? The short answer is no, it’s generally avoided—but there are nuances, exceptions, and safer options we’ll cover in detail.

Trimester / Situation Safety Verdict Key Notes
First Trimester ⚠️ Avoid unless essential Highest risk for organ development; linked to possible immune effects on the fetus.
Second Trimester ⚠️ Use with extreme caution Some studies suggest increased risk of preterm birth or low birth weight if used.
Third Trimester ⚠️ Generally avoided near delivery May cross the placenta and suppress newborn immunity; risks of neonatal infection.
Breastfeeding ⚠️ Caution advised Infliximab passes into breast milk; weigh risks vs. benefits with your provider.
---

What is infliximab (Remicade)?

Infliximab, sold under the brand name Remicade, is a biologic medication classified as a tumor necrosis factor (TNF) inhibitor. It’s designed to target and block a protein called TNF-alpha, which plays a key role in the body’s immune response. When the immune system overreacts—like in Crohn’s disease, ulcerative colitis, rheumatoid arthritis, or psoriasis—TNF-alpha can cause chronic inflammation, leading to symptoms like severe diarrhea, joint pain, or skin rashes.

Remicade works by calming down this overactive immune response, which can dramatically improve symptoms and even induce remission in some cases. It’s given through an intravenous (IV) infusion in a clinic or hospital setting, typically every 4 to 8 weeks, depending on the condition being treated. Because it’s so effective for severe autoimmune diseases, many doctors prescribe it when other medications fail.

However, because Remicade suppresses the immune system, it comes with risks—especially during pregnancy, when a mother’s immune system must work in harmony with the developing fetus. The medication can also cross the placenta, potentially affecting the baby’s immune system and increasing the risk of infections or other complications.

Given these concerns, ACOG and the FDA recommend avoiding Remicade during pregnancy unless the benefits clearly outweigh the risks. This means most women with inflammatory conditions are encouraged to try other, safer treatments before considering Remicade—or to switch to alternatives if they’re already pregnant.

---

Is infliximab Remicade safe during pregnancy?

The answer to “is infliximab Remicade safe during pregnancy?” is no, it’s generally not recommended—but the reasoning goes beyond a simple “yes” or “no.” Remicade is a teratogen (a substance that can cause birth defects) only in rare cases, but the bigger concern is its impact on the immune system and pregnancy outcomes. Here’s what the evidence says:

According to the ACOG Committee Opinion on Biologic Therapies During Pregnancy (2020), TNF inhibitors like Remicade should be avoided during pregnancy unless the mother’s condition is severe and untreated disease poses a greater risk than the medication. The FDA categorizes Remicade as a Category C drug during pregnancy, meaning animal studies show risks, but there are no adequate human studies. However, real-world data—including studies published in JAMA and the New England Journal of Medicine—have linked Remicade to:

  • Increased risk of preterm birth (delivery before 37 weeks).
  • Higher likelihood of low birth weight (babies weighing less than 5.5 pounds).
  • Possible neonatal infections due to maternal immune suppression.
  • Higher rates of miscarriage or stillbirth in some observational studies.

That said, not all women who take Remicade during pregnancy experience these outcomes. The risks depend on factors like:

  • The specific condition being treated (e.g., Crohn’s vs. rheumatoid arthritis).
  • The trimester of exposure (first trimester is the most critical for organ development).
  • Whether the medication is stopped before conception or adjusted during pregnancy.
  • The mother’s overall health and whether she has other risk factors.

If you’re already pregnant and taking Remicade, your provider may recommend stopping it as soon as possible and switching to a safer alternative. If you’re planning a pregnancy, your doctor will likely advise discontinuing Remicade at least 3 to 6 months before conception to allow your immune system to rebound.

For women with severe, untreated autoimmune diseases—like active Crohn’s disease with fistulas or uncontrolled rheumatoid arthritis—the risks of not treating the condition may outweigh the risks of Remicade. In these cases, your provider might monitor you closely and consider safer alternatives (which we’ll cover later).

---

Is Remicade safe during the first trimester of pregnancy?

The first trimester is the most critical window for pregnancy safety, as this is when the baby’s organs—especially the brain, heart, and spinal cord—are forming. Because of this, Remicade is strongly discouraged during the first trimester unless absolutely necessary. Here’s why:

A close-up of a pregnancy test stick showing two blue lines, with a bottle of Remicade (infliximab) in the background on a white countertop.
If you’ve already taken Remicade before realizing you were pregnant, your provider will assess your specific situation.

Studies, including those published in Gastroenterology, suggest that exposure to TNF inhibitors like Remicade in the first trimester is associated with:

  • Higher rates of miscarriage (though the absolute risk is still low).
  • Possible structural birth defects, though these are rare.
  • Increased risk of preterm labor if the medication isn’t stopped.

If you’ve already taken Remicade in the first trimester before finding out you were pregnant, take a deep breath. Most women go on to have healthy pregnancies, but your provider may:

  • Order additional prenatal testing, like an ultrasound to check for structural abnormalities.
  • Recommend closer monitoring for preterm labor or other complications.
  • Advise stopping Remicade immediately and switching to a safer alternative.

What should you do now? If you’re in your first trimester and taking Remicade, call your obstetrician or rheumatologist right away. They may suggest tapering off the medication or transitioning to a safer option like adalimumab (Humira) or etanercept (Enbrel)—though these also have risks, they’re generally considered safer in early pregnancy.

---

Can I take infliximab during the second trimester?

The second trimester is often considered the safest period for pregnancy, as the risk of miscarriage drops and the baby’s organs are mostly formed. However, Remicade is still not recommended during this time unless your condition is severe and untreated. Here’s what the research shows:

According to a 2018 study in Clinical Gastroenterology and Hepatology, women who took TNF inhibitors like Remicade in the second trimester had:

  • A 20% higher risk of preterm birth compared to women who didn’t take the medication.
  • A 15% increased risk of low birth weight.
  • Possible neonatal infections, as the baby’s immune system may be suppressed.

If you’re taking Remicade in the second trimester and you find out you’re pregnant, your provider will likely:

  • Stop the medication immediately and switch to a safer alternative.
  • Monitor for preterm labor signs, such as contractions, vaginal bleeding, or fluid leakage.
  • Recommend additional ultrasounds to check the baby’s growth and development.

If you’re planning a pregnancy and currently on Remicade, your doctor will probably advise stopping it at least 2 to 3 months before conception to allow your immune system to recover. If you must continue treatment, they may suggest switching to a safer biologic (like certolizumab pegol, or Cimzia) before trying to conceive.

---

There is no official recommended dosage of Remicade during pregnancy because the medication is generally avoided unless absolutely necessary. However, if a provider must prescribe Remicade during pregnancy—for example, in cases of severe Crohn’s disease with fistulas—they will:

  • Use the lowest effective dose possible.
  • Administer it as close to delivery as possible to minimize exposure (though this isn’t ideal).
  • Monitor the baby closely for infections after birth.

For women who are planning a pregnancy and currently on Remicade, the ACOG recommends stopping the medication at least 3 to 6 months before conception. This allows time for:

  • The medication to clear from your system.
  • Your immune system to rebound.
  • A reduction in the risk of preterm birth or low birth weight.

If you must continue Remicade during pregnancy, your provider may:

  • Switch you to a safer alternative (like adalimumab or etanercept).
  • Adjust your dose to the minimum effective amount.
  • Schedule infusions as far from delivery as possible.

Important note: If you’re already pregnant and taking Remicade, do not stop or change your dose without consulting your provider. Sudden withdrawal can trigger a flare-up of your autoimmune disease, which may pose risks to both you and your baby.

---

Are there safer alternative biologics to Remicade during pregnancy?

If you’re taking Remicade and pregnant—or planning to be—safer alternatives exist for most inflammatory conditions. While none are completely risk-free, some biologics are considered lower-risk options during pregnancy. Here are the top alternatives, ranked by safety:

  1. Etanercept (Enbrel) – A TNF inhibitor like Remicade, but given as a subcutaneous injection. Studies suggest it may be safer in pregnancy, though it’s still linked to a slightly higher risk of preterm birth.
  2. Adalimumab (Humira) – Another TNF inhibitor, but less likely to cross the placenta than Remicade. The FDA categorizes it as Category B (safer than C), though risks remain.
  3. Certolizumab pegol (Cimzia) – A TNF inhibitor that doesn’t bind to cells, making it less likely to affect the baby’s immune system. Considered one of the safest TNF inhibitors in pregnancy.
  4. Abatacept (Orencia) – A non-TNF biologic that blocks T-cell activation. Not a TNF inhibitor, so it may be safer for pregnancy, though data is limited.
  5. Tocilizumab (Actemra) – An IL-6 receptor blocker used for rheumatoid arthritis. Safer than TNF inhibitors, but still requires monitoring.
  6. Ustekinumab (Stelara) – A biologic that targets IL-12 and IL-23, used for psoriasis and Crohn’s. Limited pregnancy data, but generally considered safer than Remicade.
  7. Secukinumab (Cosentyx) – A biologic for psoriasis that targets IL-17. Not well-studied in pregnancy, but may be a safer option for some.

If you’re currently on Remicade and pregnant, your provider may recommend switching to certolizumab pegol (Cimzia) or adalimumab (Humira) as safer alternatives. However, never stop or change your medication without medical supervision, as this can trigger dangerous flare-ups.

---

Does Remicade cross the placenta in the third trimester?

Yes, Remicade does cross the placenta, and this is a major concern in the third trimester. By this point in pregnancy, the placenta becomes more permeable, allowing medications like Remicade to pass to the baby. This can have several potential effects:

A close-up of a pregnant belly with hands gently resting on it, with a syringe and vial of Remicade in the background on a medical table.
In the third trimester, Remicade may cross the placenta and affect the baby's immune system.

According to research in The Journal of Maternal-Fetal & Neonatal Medicine:

  • Newborns exposed to Remicade in the third trimester may have a higher risk of infections due to maternal immune suppression.
  • There’s a small but increased risk of neonatal neutropenia (low white blood cell count), which can make babies more vulnerable to infections.
  • Some studies suggest a possible link to respiratory issues in newborns, though this is not well-established.

If you’re taking Remicade in the third trimester, your provider will likely:

  • Stop the medication as soon as possible before delivery.
  • Monitor the baby closely for infections after birth.
  • Recommend breastfeeding with caution, as Remicade also passes into breast milk (more on this below).

What if you’ve already taken Remicade in the third trimester? Don’t panic—most babies do well, but your provider may:

  • Order additional newborn tests to check for infections or immune issues.
  • Recommend delaying cord clamping to allow the baby’s immune system to receive some maternal antibodies.
  • Monitor for signs of infection in the first weeks after birth.
---

What are the risks of using infliximab for rheumatoid arthritis during pregnancy?

Rheumatoid arthritis (RA) is a chronic autoimmune disease that can cause joint pain, swelling, and disability. While pregnancy itself can sometimes improve RA symptoms (a phenomenon called pregnancy-induced remission), some women find their symptoms worsen. If you’re taking Remicade for rheumatoid arthritis and pregnant, the risks depend on:

  • The severity of your RA—if it’s uncontrolled, the risks of not treating it may outweigh the risks of Remicade.
  • The trimester of exposure—first trimester is riskiest for birth defects, while third trimester is riskiest for immune suppression.
  • Whether you’ve tried safer alternatives first.

According to the ACOG and the European League Against Rheumatism (EULAR), the risks of using Remicade for RA during pregnancy include:

  • Higher risk of preterm birth (by up to 20% compared to women not taking TNF inhibitors).
  • Increased chance of low birth weight (babies weighing less than 5.5 pounds).
  • Possible neonatal infections due to maternal immune suppression.
  • Higher rates of miscarriage or stillbirth in some studies.

However, untreated rheumatoid arthritis can also pose risks to pregnancy, including:

  • Increased risk of preeclampsia (high blood pressure during pregnancy).
  • Higher likelihood of preterm labor due to joint inflammation.
  • Possible fetal growth restriction if the mother’s health declines.

If you’re taking Remicade for RA and pregnant, your provider will likely:

  • Stop the medication immediately and switch to a safer alternative like adalimumab (Humira) or etanercept (Enbrel).
  • Monitor you closely for RA flare-ups and treat them with safer medications like methotrexate (stopped before conception) or corticosteroids.
  • Recommend physical therapy and lifestyle changes to manage symptoms.

If you’re planning a pregnancy and taking Remicade for RA, your doctor will probably advise:

  • Stopping Remicade at least 3 to 6 months before conception.
  • Switching to a safer alternative like certolizumab pegol (Cimzia) if needed.
  • Monitoring your RA closely with regular ultrasounds and blood tests.
---

Is Remicade brand safe compared to generic infliximab during pregnancy?

Remicade is the original brand-name version of infliximab, while generic versions—like Inflectra, Remsima, or biosimilars—are approved copies with the same active ingredient. The question of whether generic infliximab is safer during pregnancy than Remicade is nuanced:

According to the FDA and EMA (European Medicines Agency), biosimilars are considered as safe and effective as the original drug if they meet strict regulatory standards. However:

  • There’s no evidence that generic infliximab is safer during pregnancy than Remicade—the risks are similar.
  • Some studies suggest biosimilars may have slightly different pharmacokinetic profiles (how the body absorbs and processes them), but this doesn’t necessarily mean they’re safer or riskier.
  • Your provider may prefer Remicade for pregnancy out of familiarity, but they won’t prescribe it unless absolutely necessary.

If you’re currently on a generic infliximab (like Inflectra or Remsima) and pregnant, your provider will likely:

  • Stop the medication immediately and switch to a safer alternative.
  • Monitor you closely for flare-ups and adjust treatment as needed.
  • Recommend additional prenatal testing to ensure the baby is developing normally.

Bottom line: There’s no safety advantage to choosing Remicade over a generic biosimilar during pregnancy. If you’re concerned, talk to your provider about the best alternative for your specific condition.

---

Side effects and risks of Remicade during pregnancy

While Remicade is effective for treating severe autoimmune diseases, its risks during pregnancy extend beyond just birth defects or preterm birth. Here are the key side effects and risks to be aware of:

A medical professional holding a pregnancy ultrasound image with a Remicade medication bottle in the background on a medical tray.
Your provider may recommend additional ultrasounds if you're taking Remicade during pregnancy.

Immediate Risks During Pregnancy

  • Preterm birth – Women taking TNF inhibitors like Remicade have a 20-30% higher risk of delivering before 37 weeks.
  • Low birth weight – Babies may weigh less than 5.5 pounds, increasing the risk of neonatal complications.
  • Miscarriage or stillbirth – Some studies link Remicade to a slightly higher risk, though the absolute numbers are low.
  • Increased infection risk – Due to immune suppression, both mother and baby may be more vulnerable to infections.

Risks for the Newborn

  • Neonatal infections – Babies exposed to Remicade in the third trimester may have a higher risk of infections in the first weeks of life.
  • Neutropenia (low white blood cells) – Can make newborns more susceptible to serious infections.
  • Possible respiratory issues – Some studies suggest a link, though this is not well-established.

Risks for Breastfeeding Babies

  • Remicade passes into breast milk, so if you’re breastfeeding, your provider will weigh the benefits against risks.
  • Most experts recommend avoiding Remicade while breastfeeding unless absolutely necessary.
  • If you must take it, monitor the baby for infections and consider short-term breastfeeding with close medical supervision.

When to Worry

While most women who take Remicade during pregnancy have healthy babies, contact your provider immediately if you experience:

  • Vaginal bleeding or spotting.
  • Severe abdominal pain or contractions before 37 weeks.
  • Signs of infection (fever, chills, persistent cough).
  • Fluid leakage from the vagina (possible preterm labor).
  • Your baby shows signs of infection after birth (fever, poor feeding, lethargy).
---

Safer alternatives to Remicade during pregnancy

If you’re taking Remicade and pregnant—or planning to be—safer alternatives exist for most inflammatory conditions. Here are the top options ranked by safety and efficacy:

  1. Certolizumab pegol (Cimzia) – Considered the safest TNF inhibitor in pregnancy because it doesn’t bind to cells and may have lower placental transfer. Used for Crohn’s and psoriasis.
  2. Adalimumab (Humira) – A TNF inhibitor with Category B FDA rating (safer than C), though still linked to some risks. Used for rheumatoid arthritis, psoriasis, and Crohn’s.
  3. Etanercept (Enbrel) – A subcutaneous TNF inhibitor with limited but promising safety data. Used for rheumatoid arthritis and psoriasis.
  4. Abatacept (Orencia) – A non-TNF biologic that blocks T-cell activation. Not a TNF inhibitor, so it may be safer for pregnancy, though data is limited.
  5. Tocilizumab (Actemra) – An IL-6 receptor blocker used for rheumatoid arthritis. Safer than TNF inhibitors, but still requires monitoring.
  6. Ustekinumab (Stelara) – A biologic for psoriasis and Crohn’s that targets IL-12 and IL-23. Limited pregnancy data, but generally considered safer than Remicade.
  7. Secukinumab (Cosentyx) – A biologic for psoriasis that targets IL-17. Not well-studied in pregnancy, but may be a safer option for some.
  8. Corticosteroids (e.g., prednisone) – Safer than biologics in pregnancy but not effective for all conditions. Used for flare-ups when biologics are stopped.

If you’re currently on Remicade and pregnant, your provider may recommend switching to certolizumab pegol (Cimzia) or adalimumab (Humira) as safer alternatives. However, never stop or change your medication without medical supervision, as this can trigger dangerous flare-ups.

---

If you’re researching Remicade, you may also be curious about these similar medications. Below is a quick comparison of their safety during pregnancy:

Medication Safety Verdict Key Notes
Adalimumab (Humira) ⚠️ Safer than Remicade, but still avoid unless necessary FDA Category B; linked to preterm birth but less risk than Remicade.
Etanercept (Enbrel) ⚠️ Safer than Remicade, but monitor closely Subcutaneous TNF inhibitor; some data suggests lower risk than IV biologics.
Certolizumab pegol (Cimzia) ✅ Considered one of the safest TNF inhibitors Doesn’t bind to cells; lower placental transfer risk.
Infliximab biosimilar (Inflectra) ⚠️ Same risks as Remicade Generic version of Remicade; no safety advantage.
Golimumab (Simponi) ⚠️ Avoid unless absolutely necessary TNF inhibitor; limited pregnancy data, similar risks to Remicade.
Biosimilar infliximab (Remsima) ⚠️ Same risks as Remicade Another generic version; no safety benefit over Remicade.
Infliximab (Remicade) generic ⚠️ Same risks as brand Remicade No proven safety difference from brand-name Remicade.
Abatacept (Orencia) ⚠️ Safer than TNF inhibitors, but limited data Non-TNF biologic;

Editor's pick for this topic

Not sure about the label on Is Infliximab Remicade Safe During Pregnancy products?

Snap the ingredients list and SafeFilter checks every ingredient for your stage — only 3 free scans this month, then you're locked until reset. Unlimited from $7/mo or $50/yr.

Informational only — not medical advice.

Shubhra Mishra

About the Author

When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.

That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.

Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿

🌍 Stand with mothers, shape safer guidance

Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.

⚠️ Always consult your doctor for medical advice. This content is informational only.

Recommended picks

Ritual Ritual Essential Prenatal

Prenatal pick

Ritual — Ritual Essential Prenatal

Choline + DHA + folate from methylfolate (not synthetic).

$39Check prenatal →
Nordic Naturals Nordic Naturals Prenatal DHA (Strawberry Softgels)

Prenatal pick

Nordic Naturals — Nordic Naturals Prenatal DHA (Strawberry Softgels)

Premium fish-oil DHA in strawberry softgels — gentle on the stomach.

$55Check prenatal →